|Articles|September 10, 2020
- Pharmaceutical Executive-09-01-2020
- Volume 40
- Issue 9
Pharmaceutical Executive, September 2020 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive September 2020 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 5 years ago
Our Launch-Time Menuover 5 years ago
Drug Launch: Winning the Evidence Battleover 5 years ago
COVID Causes Pharma Marketers to Watch TVover 5 years ago
Succession Plan: Skyriziover 5 years ago
New Standards for First-to-Launch Playersover 5 years ago
(O)mega Opportunity: Vascepaover 5 years ago
Educational Mission: Oxbrytaover 5 years ago
First in Class: Spravatoover 5 years ago
One Time for Lifetime: Zolgensmaalmost 6 years ago
Biopharma Capital Markets Sizzle in 2020Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Future for Disease Modifying Therapies for Lysosomal Disorders
2
Kardigan Planning for $350 Million IPO Raise: Report
3
How New Technologies Are Impacting the Vaccine Market
4
Accelerating Speed to Patient: A Conversation With Eli Lilly’s Sarah O’Keeffe
5
